FDA's Overreach on Compounded Peptides BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved BPC 157 Banned: Key Facts on the Latest FDA Decision The FDA just announced a July advisory panel to review BPC 157, TB 500, and 5 more restricted peptides for legal compounding access. Full breakdown at the link in bio peptideacademy.io blog #peptides #BPC157 #